4186 logo

Taiwan Advance Bio-Pharmaceutical Inc. Stock Price

TPEX:4186 Community·NT$918.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

4186 Share Price Performance

NT$10.15
-3.45 (-25.37%)
NT$10.15
-3.45 (-25.37%)
Price NT$10.15

4186 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slight risk with mediocre balance sheet.

4 Risks
1 Reward

Taiwan Advance Bio-Pharmaceutical Inc. Key Details

NT$371.9m

Revenue

NT$120.6m

Cost of Revenue

NT$251.3m

Gross Profit

NT$227.9m

Other Expenses

NT$23.4m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
0.26
67.58%
6.29%
98.1%
View Full Analysis

About 4186

Founded
1989
Employees
165
CEO
Wen-Long Su
WebsiteView website
www.biotest.com.tw

Taiwan Advance Bio-Pharmaceutical Inc. operates in the biotechnology industry in China, Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally. The company provides food safety diagnostic testing kits; ELISA, rapid, and chemical test kits customization, and food safety lab establishment consultation services; and manufactures monoclonal and polyclonal antibody products. It also offers abused drugs rapid tests; provides cell banking services for newborn and adult stem cells storage; and operates drug testing center for urine drug test, hair drug test, and identification of drug abuse. The company was founded in 1989 and is based in Taipei, Taiwan.

Recent 4186 News & Updates

Recent updates

No updates